Therapeutic management of primary immunodeficiency in older patients

Nisha Verma1, Anthony Thaventhiran, Benjamin Gathmann

  • 1Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, UK.

Drugs & Aging
|April 23, 2013
PubMed

Insights

Primary immunodeficiency disease (PID) increasingly affects elderly patients, yet clinical evidence for their management is scarce. This review focuses on antibody deficiency syndromes, the most common PID type in older adults.

Area of Science:

  • Immunology
  • Geriatrics
  • Clinical Medicine

Background:

  • Primary immunodeficiency disease (PID) traditionally diagnosed in children.
  • Advances in diagnosis and treatment increase the number of elderly PID patients.
  • Limited research exists for managing PID in older adults.

Purpose of the Study:

  • To review the management of PID in the elderly.
  • To focus on antibody deficiency syndromes, prevalent in this demographic.

Main Methods:

  • Review of existing literature and data from the European Society for Immunodeficiencies.
  • Analysis of management strategies for elderly PID patients.
  • Focus on predominantly antibody deficiency syndromes.

Main Results:

  • Elderly PID patients are increasingly common.
  • Predominantly antibody deficiency syndromes are the most frequent PID type in the elderly.
  • Clinical management often relies on extrapolations from other patient groups.

Conclusions:

  • There is a critical need for evidence-based guidelines for elderly PID management.
  • Further research is required to optimize care for this growing patient population.
  • Antibody deficiency syndromes require specific attention in geriatric PID care.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...